Clinical Trial Update: SPD544 High Strength Bioequivalence Study [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of SPD544 (high-strength formulation) completed in ADHD participants; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• SPD544

Snippet

Sponsor: Shire | Conditions: ADHD | Phase 1 | Status: COMPLETED | Results posted: 2011-08-25